Ribomic Inc
TSE:4591
Ribomic Inc
TSE:4591
Price:
99
JPY
4.21%
Market Closed
Market Cap:
¥5.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Ribomic Inc
TSE:4591
|
JP |
|
PDS Limited
NSE:PDSL
|
IN |
|
D
|
Dongwon Systems Corp
KRX:014820
|
KR |
|
Saga Pure ASA
OSE:SAGA
|
NO |
|
Microsaic Systems PLC
LSE:MSYS
|
UK |
|
RPA Holdings Inc
TSE:6572
|
JP |
|
Teladoc Health Inc
NYSE:TDOC
|
US |
|
B
|
Belships ASA
XBER:NS6
|
NO |
|
S
|
SolidusGold Inc
XTSX:SDC
|
CA |
|
A
|
Ashford Inc
AMEX:AINC
|
US |
|
Genetic Signatures Ltd
ASX:GSS
|
AU |
|
T
|
Tidewater Renewables Ltd
TSX:LCFS
|
CA |
|
Gigas Hosting SA
MAD:GIGA
|
ES |
|
Xiamen King Long Motor Group Co Ltd
SSE:600686
|
CN |
|
S
|
SLR Senior Investment Corp
F:SL8
|
US |
|
A
|
Akerna Corp
NASDAQ:GRYP
|
US |
Relative Value
The Relative Value of one
Ribomic Inc
stock under the Base Case scenario is
hidden
JPY.
Compared to the current market price of 99 JPY,
Ribomic Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Ribomic Inc Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Ribomic Inc Competitors
Ribomic Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| JP |
|
Ribomic Inc
TSE:4591
|
5.4B JPY | 7 168.8 | -6.6 | -2.6 | -2.6 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.5B USD | 5.9 | 86.6 | 14.4 | 20 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
170.3B USD | 5.8 | 20 | 12.5 | 15.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.3B USD | 9.6 | 29.2 | 21.9 | 22.9 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.5B USD | 5.4 | 17.2 | 12.6 | 14.4 | |
| AU |
|
CSL Ltd
ASX:CSL
|
66.8B AUD | 3.1 | 34.3 | 11.3 | 14.3 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
41.3B USD | 11.1 | 131.9 | 73.8 | 82 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
